|
|
|
|
| LEADER |
01856cam a2200517 4500 |
| 001 |
PPN007562446 |
| 005 |
20240426060300.0 |
| 010 |
|
|
|a 0-85312-998-3
|b Ellis Horwood Limited
|
| 010 |
|
|
|a 0-470-21037-0
|b Halsted : v. 1
|
| 035 |
|
|
|a ocm19728507
|
| 035 |
|
|
|a sib0240145
|
| 035 |
|
|
|a DYNIX_BUNAN_146581
|
| 100 |
|
|
|a 19901022f1988 ||||0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a GB
|a US
|
| 105 |
|
|
|a a a 001yy
|
| 200 |
1 |
|
|a Drug synthesis
|f H.J. Roth and A. Kleemann
|g in collab. with T. Beisswenger
|g translated by M.D. Cooke
|
| 210 |
|
|
|a New-York
|c John Wiley & sons
|d 1988
|
| 215 |
|
|
|a 407 p.
|c ill.
|d 25 cm
|
| 225 |
1 |
|
|a Ellis Horwood series in pharmaceutical technology
|
| 300 |
|
|
|a Trad. de : Arzneistoffsynthese
|
| 320 |
|
|
|a Index
|
| 410 |
|
| |
|0 013490362
|t Ellis Horwood series in pharmaceutical technology
|f ed. M. H. Rubinstein
|c Chichester
|n E. Horwood
|n J. Wiley
|d 1987-...
|
| 454 |
|
| |
|t Arzneistoffsynthese
|
| 461 |
|
| |
|t Pharmaceutical chemistry
|v 1
|
| 517 |
| |
|
|a Pharmaceutical chemistry
|j 1
|
| 517 |
| |
|
|a Drug synthesis
|
| 606 |
|
|
|3 PPN04068010X
|a Chimie pharmaceutique
|2 fmesh
|
| 606 |
|
|
|3 PPN040802639
|a Conception de médicament
|2 fmesh
|
| 606 |
|
|
|3 PPN027797996
|a Chimie pharmaceutique
|2 rameau
|
| 606 |
|
|
|3 PPN027239144
|a Médicaments
|3 PPN027790169
|x synthèse
|2 rameau
|
| 676 |
|
|
|a 615.19
|
| 686 |
|
|
|a QV 744
|2 usnlm
|
| 700 |
|
1 |
|a Roth
|b Hermann J.
|
| 701 |
|
1 |
|3 PPN068664095
|a Kleemann
|b Axel
|f 1940-....
|c chimiste
|
| 702 |
|
1 |
|a Beisswenger
|b T.
|4 070
|
| 702 |
|
1 |
|a Cooke
|b M.D
|4 730
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20050504
|g AFNOR
|
| 801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
| 801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b SF
|g AFNOR
|
| 915 |
|
|
|5 441092104:179192663
|a 1160459105
|b 1160459105
|
| 919 |
|
|
|5 441092104:179192663
|a 1160459105
|
| 930 |
|
|
|5 441092104:179192663
|b 441092104
|a 615 ROT
|j u
|
| 979 |
|
|
|a SCI
|
| 998 |
|
|
|a 256666
|
Nantilus
